Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Medtronic and Sequoia Start $60 Million China Healthcare Fund

publication date: Nov 13, 2015
Medtronic PLC, a global medical device maker, has partnered with Sequoia Capital to establish a $60 million joint investment fund, which will invest in healthcare technology startups aimed at China's market. Suzhou BioBay joined as a limited and strategic partner. The ideal investment candidate will be a new China company with the potential to succeed in global markets. Ex-China companies that are developing products suited for the China market will also be considered. More details....

Stock Symbol: (NYSE: MDT)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital